Investor Relations / Financial InformationConsolidated Financial Highlights
Statements of Income
Swipe the screen to view more.(Billion yen)
| Net Sales | Operating Profit | Ordinary Profit | Profit Attributable to Owners of Parent | |
2020/3 |
412.8 |
29.6 |
31.8 |
5.0 |
2021/3 |
393.6 |
31.7 |
34.7 |
19.7 |
2022/3 |
467.9 |
50.7 |
57.3 |
31.3 |
2023/3 |
538.0 |
47.5 |
52.0 |
40.7 |
2024/3 |
558.1 |
62.4 |
68.4 |
55.8 |
Segment Information
Sales and Operating Profit of the fiscal year ended March 2024 (By segment)
Swipe the screen to view more.(Billion yen)
| Net Sales | Operating Profit | Operating Profit Margin(%) | |
Medical/ |
13.9 |
0.8 |
5.7 |
Smart |
30.7 |
- 2.9 |
- |
Safety |
95.6 |
3.0 |
3.1 |
Materials |
185.3 |
42.7 |
23.1 |
Engineering |
226.8 |
18.3 |
8.1 |
Others |
5.7 |
0.4 |
7.4 |
Consolidated |
558.1 |
62.4 |
11.2 |
Medical / Healthcare
Swipe the screen to view more.(Billion yen)
Net Sales |
Operating Profit |
Operating Profit Margin (%) |
|
2022/3 |
19.5 |
3.4 |
17.6 |
2023/3 |
16.6 |
1.3 |
7.6 |
2024/3 |
13.9 |
0.8 |
5.7 |
Smart
Swipe the screen to view more.(Billion yen)
Net Sales |
Operating Profit |
Operating Profit Margin (%) |
|
2022/3 |
32.5 |
5.8 |
17.8 |
2023/3 |
29.6 |
- 0.6 |
- |
2024/3 |
30.7 |
- 2.9 |
- |
Safety
Swipe the screen to view more.(Billion yen)
Net Sales |
Operating Profit |
Operating Profit Margin (%) |
|
2022/3 |
69.5 |
5.2 |
7.5 |
2023/3 |
84.0 |
0.5 |
0.6 |
2024/3 |
95.6 |
3.0 |
3.1 |
Material
Swipe the screen to view more.(Billion yen)
Net Sales |
Operating Profit |
Operating Profit Margin (%) |
|
2022/3 |
122.8 |
24.8 |
20.2 |
2023/3 |
160.8 |
20.7 |
12.9 |
2024/3 |
185.3 |
42.7 |
23.1 |
Engineering Plastics
Swipe the screen to view more.(Billion yen)
Net Sales |
Operating Profit |
Operating Profit Margin (%) |
|
2022/3 |
212.3 |
25.8 |
12.1 |
2023/3 |
238.1 |
25.3 |
10.6 |
2024/3 |
226.8 |
18.3 |
8.1 |
Others
Swipe the screen to view more.(Billion yen)
Net Sales |
Operating Profit |
Operating Profit Margin (%) |
|
2022/3 |
11.4 |
1.8 |
15.5 |
2023/3 |
9.1 |
0.3 |
3.8 |
2024/3 |
5.7 |
0.4 |
7.4 |
*Net Sales and Operating Profit by segment for FY2023/3 are the figure after segment changing in the Cosmetics Raw Material 1,3-BG (Medical / Healthcare → Material) and Novel Drug Delivery Devices R&D functions (Safety → Medical / Healthcare).
Balance Sheets
Swipe the screen to view more.(Billion yen)
Net Assets |
Total Assets |
Interest-bearing liabilities |
|
2020/3 |
392.6 |
598.0 |
92.8 |
2021/3 |
245.0 |
640.4 |
270.9 |
2022/3 |
279.5 |
698.8 |
283.6 |
2023/3 |
310.4 |
765.6 |
322.0 |
2024/3 |
374.9 |
839.2 |
304.1 |
Cash Flow
Swipe the screen to view more.(Billion yen)
Cash Flows from |
Cash Flows from |
Cash Flows from |
Cash and Cash Equivalents |
|
2020/3 |
57.2 |
- 45.9 |
- 47.9 |
80.7 |
2021/3 |
57.9 |
- 34.2 |
- 17.1 |
90.7 |
2022/3 |
43.0 |
- 46.5 |
- 5.5 |
88.0 |
2023/3 |
26.8 |
- 44.1 |
20.0 |
93.5 |
2024/3 |
76.7 |
- 55.4 |
- 52.4 |
- 68.4 |
Per Share Information
Swipe the screen to view more.
Basic Net Income per Share (yen) |
Net Assets per Share (yen) |
Cash Dividends per Share (yen) |
|
2020/3 |
15.49 |
1,166.56 |
34.00 |
2021/3 |
65.18 |
789.34 |
32.00 |
2022/3 |
104.14 |
919.88 |
34.00 |
2023/3 |
138.87 |
1,033.52 |
38.00 |
2024/3 |
197.56 |
1,301.21 |
50.00 |
Financial Indicators
Swipe the screen to view more.
EBITDA (Billion yen) |
Operating Profit Ratio (%) |
ROIC (%) |
ROE (%) |
ROA (%) |
Total Asset Turnover (times per year) |
Capital Adequacy Ratio (%) |
Dividend Payout Ratio (%) |
Total return ratio (%) |
|
2020/3 |
59.8 |
7.2 |
3.8 |
1.3 |
0.8 |
0.7 |
60.6 |
219.5 |
577.3 |
2021/3 |
59.1 |
8.1 |
4.1 |
6.6 |
3.2 |
0.6 |
37.1 |
49.1 |
91.1 |
2022/3 |
78.9 |
10.8 |
6.2 |
12.3 |
4.7 |
0.7 |
38.9 |
32.6 |
48.6 |
2023/3 |
79.1 |
8.8 |
5.3 |
14.3 |
5.6 |
0.7 |
38.6 |
27.4 |
51.7 |
2024/3 |
96.1 |
11.2 |
6.3 |
17.1 |
7.0 |
0.7 |
42.8 |
25.3 |
52.0 |
Other Data
Swipe the screen to view more.(Billion yen)
Capital Expenditures |
Depreciation and Amortization |
Research and Development Expenses |
Number of Employees |
|
2020/3 |
47.6 |
29 |
21.3 |
11,606 |
2021/3 |
39.6 |
25.8 |
19.5 |
11,142 |
2022/3 |
40.8 |
26.9 |
20.7 |
11,104 |
2023/3 |
56.3 |
30.8 |
21.9 |
11,207 |
2024/3 |
77.5 |
33.0 |
23.4 |
11,134 |
Note: Amortization of Goodwill is not included in Depreciation and Amortization.
You can download 12-Years consolidated financial data in Excel format.